# Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint Dislocation

> **NCT05863286** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 28 (estimated)

## Conditions studied

- Dislocation of Temporomandibular Joint TMJ
- Subluxation of Temporomandibular Joint

## Interventions

- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT05863286
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-30
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05863286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05863286, "Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint Dislocation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05863286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
